Brief Summary
MARKER STUDY IS PUBLISHED: A study was published on Thursday, July 17, 1997
which identifies a possible biological marker for CFS. This work was
first described by lead researcher Robert Suhadolnik at last October's
AACFS conference in San Francisco. The study shows a unique enzyme
present in CFS patients that does not appear in healthy controls. Also,
two studies in Europe have confirmed this study and will be published
later this year, according to remarks made by Suhadolnik at a
Congressional briefing given on May 16 in Washington, DC. The current
paper was published as:
Suhadolnik RJ, Peterson DL, O'Brien K, Cheney PR, Herst CVT, Reichenbach
NL, Ning K, Horvath SE, Iacono KT, Adelson ME, De Meirleir K, De Becker P,
Charubala R, Pfleiderer W.
Biochemical Evidence for a Novel Low Molecular
Weight 2-5A-Dependent RNase L in Chronic Fatigue Syndrome. Journal of
Interferon and Cytokine Research, July 1997, 17:377-385.
Robert Suhadolnik, Ph.D., is a professor of biochemistry at Temple
University School of Medicine in Philadelphia and is a member of the
university's Fels Institute for Cancer Research and Molecular Biology.
His laboratory has been involved in studies of virus-associated diseases
and cancers for the past 15 years and has been awarded research grants by
the National Institutes of Health to study CFS, and AIDS.
Back to the top